Abstract
Shiga-toxin (Stx)-producing Escherichia coli hemolytic-uremic syndrome (STEC-HUS) is one of the most common causes of acute kidney injury in children. Stx-mediated endothelial injury initiates the cascade leading to thrombotic microangiopathy (TMA), still the exact pathogenesis remains elusive. Interestingly, there is wide variability in clinical presentation and outcome. One explanation for this could be the enhancement of TMA through other factors. We hypothesize that heme, as released during extensive hemolysis, contributes to the etiology of TMA. Plasma levels of heme and its scavenger hemopexin and degrading enzyme heme-oxygenase-1 (HO-1) were measured in 48 STEC-HUS patients. Subsequently, the effect of these disease-specific heme concentrations, in combination with Stx, was assessed on primary human glomerular microvascular endothelial cells (HGMVECs). Significantly elevated plasma heme levels up to 21.2 µM were found in STEC-HUS patients compared to controls and were inversely correlated with low or depleted plasma hemopexin levels (R2 −0.74). Plasma levels of HO-1 are significantly elevated compared to controls. Interestingly, especially patients with high heme levels (n = 12, heme levels above 75 quartile range) had high plasma HO-1 levels with median of 332.5 (86–720) ng/ml (p = 0.008). Furthermore, heme is internalized leading to a significant increase in reactive oxygen species production and stimulated both nuclear translocation of NF-κB and increased levels of its target gene (tissue factor). In conclusion, we are the first to show elevated heme levels in patients with STEC-HUS. These increased heme levels mediate endothelial injury by promoting oxidative stress and a pro-inflammatory and pro-thrombotic state. Hence, heme may be a contributing and driving factor in the pathogenesis of STEC-HUS and could potentially amplify the cascade leading to TMA.
Highlights
Renal thrombotic microangiopathy (TMA) is a heterogeneous group of disorders, characterized by vascular occlusion of capillaries due to thrombus formation, leading to thrombocytopenia, hemolytic anemia, and acute kidney injury [1, 2]
A median of 3.2 (0.5–21.2) μM heme was found in STEC-hemolytic-uremic syndrome (HUS) patients compared to 1.8 (0.6–3.8) μM in healthy controls (Figure 1A)
We are the first to show elevated heme levels in patients with STEC-HUS. These increased levels of extracellular heme are associated with depleted hemopexin and increased expression of HO-1 in plasma, suggesting cellular damage, oxidative and inflammatory stress
Summary
Renal thrombotic microangiopathy (TMA) is a heterogeneous group of disorders, characterized by vascular occlusion of capillaries due to thrombus formation, leading to thrombocytopenia, hemolytic anemia, and acute kidney injury [1, 2]. The most common cause of TMA is a gastro-intestinal infection with Shiga-toxin (Stx)-producing Escherichia coli (STEC) [2, 3]. It is believed that Stx, an AB toxin, as produced by STEC is the most important factor resulting in the development of hemolytic-uremic syndrome (HUS). After the uptake of the A subunit of Stx into the cell, cellular activation and damage is caused together with the promotion of a pro-inflammatory and pro-thrombotic state, leading to TMA [6]. There is wide variability in clinical presentation and outcome in STEC-HUS ranging from no chronic sequelae to hypertension, proteinuria, end stage renal disease, or even death [2]. One possible explanation for this broad range of clinical outcome could be the enhancement of TMA through additional factors causing endothelial damage
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.